Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elamipretide in primary mitochondrial myopathy
NCT02805790Phase 2Completed
- Sponsor
- Stealth BioTherapeutics
- Start
- Aug 2016
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elamipretide in primary mitochondrial myopathy (PMM), sponsored by Stealth BioTherapeutics. Started Aug 2016; status: completed.
02
Drugs
elamipretide
03
Conditions
primary mitochondrial myopathy (PMM)
Beyond the preview
Go deeper on NCT02805790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805790.